These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7729787)

  • 1. Liver glucokinase: decreased activity in patients with type II diabetes.
    Caro JF; Triester S; Patel VK; Tapscott EB; Frazier NL; Dohm GL
    Horm Metab Res; 1995 Jan; 27(1):19-22. PubMed ID: 7729787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Swiss journey through the clinical and genetic characteristics of diabetes in young patients].
    Dussoix P; Tappy L; Philippe J
    Schweiz Med Wochenschr; 1998 Jan; 128(5):162-6. PubMed ID: 9522422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus.
    Karvonen I; Stengård JH; Huupponen R; Stenbäck FG; Sotaniemi EA
    Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in glucokinase activators for the treatment of type 2 diabetes.
    Pal M
    Drug Discov Today; 2009 Aug; 14(15-16):784-92. PubMed ID: 19520181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus.
    Chiu KC; McCarthy JE
    Biochem Biophys Res Commun; 1996 Apr; 221(3):614-8. PubMed ID: 8630009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus.
    Froguel P; Vaxillaire M; Sun F; Velho G; Zouali H; Butel MO; Lesage S; Vionnet N; Clément K; Fougerousse F
    Nature; 1992 Mar; 356(6365):162-4. PubMed ID: 1545870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y; Donahue EP; Shiota M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of liver specific glucokinase gene knockout mice: a new animal model for screening anti-diabetic drugs.
    Zhang YL; Tan XH; Xiao MF; Li H; Mao YQ; Yang X; Tan HR
    Acta Pharmacol Sin; 2004 Dec; 25(12):1659-65. PubMed ID: 15569412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes.
    Cusi KJ; Pratipanawatr T; Koval J; Printz R; Ardehali H; Granner DK; Defronzo RA; Mandarino LJ
    Metabolism; 2001 May; 50(5):602-6. PubMed ID: 11319725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes.
    McCarty MF
    Med Hypotheses; 1999 May; 52(5):401-6. PubMed ID: 10416947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes.
    Stoffel M; Patel P; Lo YM; Hattersley AT; Lucassen AM; Page R; Bell JI; Bell GI; Turner RC; Wainscoat JS
    Nat Genet; 1992 Oct; 2(2):153-6. PubMed ID: 1303265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects.
    Belfiore F; Romeo F; Iannello S; Salamone C
    Biochem Med Metab Biol; 1989 Feb; 41(1):77-80. PubMed ID: 2540781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the potential of glucokinase activators in diabetes therapy.
    Matschinsky FM
    Nat Rev Drug Discov; 2009 May; 8(5):399-416. PubMed ID: 19373249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian glucokinase.
    Printz RL; Magnuson MA; Granner DK
    Annu Rev Nutr; 1993; 13():463-96. PubMed ID: 8369155
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of altered glucokinase gene copy number on blood glucose homoeostasis.
    Niswender KD; Postic C; Shiota M; Jetton TL; Magnuson MA
    Biochem Soc Trans; 1997 Feb; 25(1):113-7. PubMed ID: 9056854
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucokinase and non-insulin-dependent diabetes.
    O'Rahilly S
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):17-9. PubMed ID: 8348703
    [No Abstract]   [Full Text] [Related]  

  • 20. Tweaking the glucose sensor: adjusting glucokinase activity with activator compounds.
    Printz RL; Granner DK
    Endocrinology; 2005 Sep; 146(9):3693-5. PubMed ID: 16105828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.